Advanced search
Publication Cover
International Journal of Cardiovascular Interventions Volume 5, 2003 - Issue 2
Journal homepage
6
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Distal embolization at the site of a stenotic distal anastomosis of a saphenous vein graft, leading to dye entrapment

Konstantinos Toutouzas Department of Interventional Cardiology, Centro Cuore Columbus, Milan, Italy
,
Jorgo Kostov Department of Interventional Cardiology, Centro Cuore Columbus, Milan, Italy
&
Antonio Colombo Department of Interventional Cardiology, Centro Cuore Columbus, Milan, Italy
Pages 84-87 | Published online: 10 Jul 2009

  • Holmes DR Jr, Topol EJ, Califf RM et al. A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions. CAVEAT-II Investigators. Circulation 1995; 91: 1966-74.
  • Hong MK, Popma JJ, Pichard AD et al. Clinical significance of distal embolization after transluminal extraction atherectomy in diffusely diseased saphenous vein grafts. Am Heart J 1994; 127: 1496-503.
  • Le May MR, Labinaz M, Marquis JF et al. Predictors of long-term outcome after stent implantation in a saphenous vein graft. Am J Cardiol 1999; 83: 681-86.
  • Patil CV, Nikolsky E, Beyar R. Saphenous vein graft interventions: still far away from the goal. J Invas Cardiol 2001; 13: 453-55.
  • Myler R, Thorpe P, Holmes D Jr et al. Vein graft disease: avoiding problems. J Invas Cardiol 2001; 13: 489-92.
  • Hong MK, Mehran R, Dangas G et al. Are we making progress with percutaneous saphenous vein graft treatment? A comparison of 1990 to 1994 and 1995 to 1998 results. J Am Coll Cardiol 2001; 38: 150-54.
  • Webb JG, Khatri S. Distal embolization and no-reflow in the setting of saphenous vein graft in-stent restenosis. J Invas Cardiol 2001; 13: 451-52.
  • Webb JG, Carere RG, Virmani R et al. Retrieval and analysis of particulate debris after saphenous vein graft intervention. J Am Coll Cardiol 1999; 34: 468-75.
  • Hong MK, Mehran R, Dangas G et al. Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. Circulation 1999; 100: 2400-405.
  • Mak KH, Challapalli R, Eisenberg MJ, Anderson KM, Califf RM, Topol EJ. Effect of platelet glycoprotein IIb/IIIa receptor inhibition on distal embolization during percutaneous revascularization of aortocoronary saphenous vein grafts. EPIC Investigators. Am J Cardiol 1997; 80: 985-88.
  • Ellis SG, Lincoff AM, Miller D et al. Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology. EPIC and EPILOG Investigators. J Am Coll Cardiol 1998; 32: 1619-23.
  • Mathew V, Grill DE, Scott CG et al. The influence of abciximab use on clinical outcome after aortocoronary vein graft interventions. J Am Coll Cardiol 1999; 34: 1163-69.
  • Robinson N, Barakat K, Dymond D. Platelet IIb/IIIa antagonists followed by delayed stent implantation. A new treatment for vein graft lesions containing massive thrombus. Heart 1999; 81: 434-37.
  • Carlino M, De Gregorio J, Di Mario C et al. Prevention of distal embolization during saphenous vein graft lesion angioplasty. Experience with a new temporary occlusion and aspiration system. Circulation 1999; 99: 3221-23.
  • Shaknovich A, Forman ST, Parikh MA et al. Novel distal occluder washout method for prevention of no-reflow during stenting of saphenous vein grafts. Cathet Cardiovasc Intervent 1999; 47: 397-403.
  • Webb JG. Is the `direct' approach best? J Invas Cardiol 2000; 12: 203-205.
  • Briguori C, De Gregorio J, Nishida T et al. Polytetrafluoroethylene-covered stent for the treatment of narrowings in aorticocoronary saphenous vein grafts. Am J Cardiol 2000; 86: 343-46.
  • Stefanadis C, Toutouzas K, Tsiamis E et al. Total reconstruction of a diseased saphenous vein graft by means of conventional and autologous tissue-coated stents. Cathet Cardiovasc Diagn 1998; 43: 318-21.
  • Stefanadis C, Tsiamis E, Vlachopoulos C et al. Autologous vein graft-coated stents for the treatment of thrombus-containing coronary artery lesions. Cathet Cardiovasc Diagn 1997; 40: 217-22.
  • Kaplan BM, Benzuly KH, Kinn JW et al. Treatment of no-reflow in degenerated saphenous vein graft interventions: comparison of intracoronary verapamil and nitroglycerin. Cathet Cardiovasc Diagn 1996; 39: 113-18.
  • Fischell TA, Carter AJ, Foster MT et al. Reversal of `no reflow' during vein graft stenting using high velocity boluses of intracoronary adenosine. Cathet Cardiovasc Diagn 1998; 45: 360-65.
  • Hillegass WB, Dean NA, Liao L, Rhinehart RG, Myers PR. Treatment of no-reflow and impaired flow with the nitric oxide donor nitroprusside following percutaneous coronary interventions: initial human clinical experience. J Am Coll Cardiol 2001; 37: 1335-43.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.